Related Experiment Video
Updated: Jan 9, 2026

09:23
Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
6.6K
High-sensitivity and high-specificity optical fiber SPR doxorubicin sensor enabled by Ti3C2 MXene sensitization
Like Li1, Yi Li2, Guohong Zou2
1College of Information Science and Engineering, Northeastern University, Shenyang, 110819, China; Hebei Key Laboratory of Micro-Nano Precision Optical Sensing and Measurement Technology, Qinhuangdao, 066004, China.
Talanta
|December 2, 2025
Summary
This study introduces a novel Ti3C2 MXene-sensitized fiber surface plasmon resonance (SPR) sensor for real-time doxorubicin monitoring. This advanced sensor enhances chemotherapy efficacy and patient safety by providing sensitive and specific drug concentration detection.
Area of Science:
- Biomedical Engineering
- Materials Science
- Analytical Chemistry
Background:
- Doxorubicin is a vital chemotherapy drug with a narrow therapeutic window, necessitating precise monitoring.
- Real-time doxorubicin concentration tracking is crucial for optimizing treatment efficacy and minimizing adverse effects.
Purpose of the Study:
- To develop a highly sensitive and specific sensor for real-time doxorubicin detection.
- To improve doxorubicin monitoring in chemotherapy patients for enhanced safety and treatment outcomes.
Main Methods:
- Fabrication of a fiber surface plasmon resonance (SPR) sensor functionalized with Ti3C2 MXene.
- Covalent modification of the SPR sensor with doxorubicin-specific aptamers.
- Characterization of sensor performance, including sensitivity, specificity, and limit of detection.
Main Results:
- Ti3C2 MXene sensitization increased refractive index sensitivity by 60.0%.
- The aptamer-modified sensor achieved high sensitivity (0.24 nm/μM) and specificity for doxorubicin detection within a 10-100 μM range.
- A low limit of detection (2.79 μM) was achieved, with successful application in real serum samples.
Conclusions:
- The developed Ti3C2 MXene-SPR sensor offers a promising platform for sensitive and specific doxorubicin monitoring.
- The sensor's characteristics, including fast response and small size, meet clinical requirements for chemotherapy patient management.
- This technology has the potential to significantly improve personalized chemotherapy and patient safety.

